Editas Medicine, Inc. (EDIT) by event type
EDIT moves most on analyst downgrades — a median of -2.28% at 30 minutes across 25 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the EDIT overview →
How EDIT reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,643 of 2,717 | 28 | -1.20% | 43% | -0.76% |
| Analyst downgrades 2,548 of 2,603 | 25 | -2.28% | 36% | -3.03% |
| Rating reiterations 3,273 of 3,522 | 43 | -0.43% | 33% | -0.66% |
| Price-target cuts 1,125 of 1,527 | 18 | -0.13% | 44% | -0.72% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how EDIT usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target cuts → · EDIT overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cerus Corporation (CERS) | 255 | +0.09% | 52% |
| Avalon GloboCare Corp. (AVCO) | 254 | 0.00% | 41% |
| Nevro Corp. (NVRO) | 253 | 0.00% | 49% |
| DarioHealth Corp. (DRIO) | 252 | 0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.